These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33559024)

  • 41. PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.
    Tai CM; Huang CK; Tu HP; Hwang JC; Chang CY; Yu ML
    Surg Obes Relat Dis; 2015; 11(4):888-94. PubMed ID: 25240529
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma metabolic alterations in patients with severe obesity and non-alcoholic steatohepatitis.
    Cabré N; Luciano-Mateo F; Baiges-Gayà G; Fernández-Arroyo S; Rodríguez-Tomàs E; Hernández-Aguilera A; París M; Sabench F; Del Castillo D; López-Miranda J; Menéndez JA; Camps J; Joven J
    Aliment Pharmacol Ther; 2020 Feb; 51(3):374-387. PubMed ID: 31825539
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The common marmoset as a model for the study of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Kramer JA; Grindley J; Crowell AM; Makaron L; Kohli R; Kirby M; Mansfield KG; Wachtman LM
    Vet Pathol; 2015 Mar; 52(2):404-13. PubMed ID: 24913270
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum iron levels and hepatic iron overload in nonalcoholic steatohepatitis and chronic viral hepatitis.
    Uraz S; Aygun C; Sonsuz A; Ozbay G
    Dig Dis Sci; 2005 May; 50(5):964-9. PubMed ID: 15906776
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TA allele of rs2070673 in the CYP2E1 gene is associated with lobular inflammation and nonalcoholic steatohepatitis in patients with biopsy-proven nonalcoholic fatty liver disease.
    Ma HL; Chen SD; Zheng KI; Yu Y; Wang XX; Tang LJ; Li G; Rios RS; Huang OY; Zheng XY; Xu RA; Targher G; Byrne CD; Wang XD; Chen YP; Zheng MH
    J Gastroenterol Hepatol; 2021 Oct; 36(10):2925-2934. PubMed ID: 34031913
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Indications and limitations of bariatric intervention in severely obese children and adolescents with and without nonalcoholic steatohepatitis: ESPGHAN Hepatology Committee Position Statement.
    Nobili V; Vajro P; Dezsofi A; Fischler B; Hadzic N; Jahnel J; Lamireau T; McKiernan P; McLin V; Socha P; Tizzard S; Baumann U
    J Pediatr Gastroenterol Nutr; 2015 Apr; 60(4):550-61. PubMed ID: 25591123
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis.
    Fargion S; Mattioli M; Fracanzani AL; Sampietro M; Tavazzi D; Fociani P; Taioli E; Valenti L; Fiorelli G
    Am J Gastroenterol; 2001 Aug; 96(8):2448-55. PubMed ID: 11513189
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changes in Total Homocysteine and Glutathione Levels After Laparoscopic Sleeve Gastrectomy in Children with Metabolic-Associated Fatty Liver Disease.
    Pastore A; Panera N; Mosca A; Caccamo R; Camanni D; Crudele A; De Stefanis C; Alterio A; Di Giovamberardino G; De Vito R; Francalanci P; Battaglia S; Muda AO; De Peppo F; Alisi A
    Obes Surg; 2022 Jan; 32(1):82-89. PubMed ID: 34546515
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.
    Weiner RA
    Dig Dis; 2010; 28(1):274-9. PubMed ID: 20460923
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circulating phospholipid profiling identifies portal contribution to NASH signature in obesity.
    Anjani K; Lhomme M; Sokolovska N; Poitou C; Aron-Wisnewsky J; Bouillot JL; Lesnik P; Bedossa P; Kontush A; Clement K; Dugail I; Tordjman J
    J Hepatol; 2015 Apr; 62(4):905-12. PubMed ID: 25450212
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitis.
    Ooi GJ; Meikle PJ; Huynh K; Earnest A; Roberts SK; Kemp W; Parker BL; Brown W; Burton P; Watt MJ
    J Hepatol; 2021 Sep; 75(3):524-535. PubMed ID: 33887358
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Laparoscopic Sleeve Gastrectomy Improves Nonalcoholic Fatty Liver Disease-Related Liver Damage in Adolescents by Reshaping Cellular Interactions and Hepatic Adipocytokine Production.
    Nobili V; Carpino G; De Peppo F; Caccamo R; Mosca A; Romito I; Overi D; Franchitto A; Onori P; Alisi A; Gaudio E
    J Pediatr; 2018 Mar; 194():100-108.e3. PubMed ID: 29198531
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Effect of Laparoscopic Sleeve Gastrectomy on Obesity and Obesity-related Disease : the Results of 10 Initial Cases.
    Kashihara H; Shimada M; Yoshikawa K; Higashijima J; Miyatani T; Tokunaga T; Nishi M; Takasu C; Hamada Y
    J Med Invest; 2019; 66(3.4):289-292. PubMed ID: 31656291
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of non-alcoholic steatohepatitis in patients with morbid obesity before bariatric surgery: preliminary evaluation with acoustic radiation force impulse imaging.
    Guzmán-Aroca F; Frutos-Bernal MD; Bas A; Luján-Mompeán JA; Reus M; Berná-Serna Jde D; Parrilla P
    Eur Radiol; 2012 Nov; 22(11):2525-32. PubMed ID: 22648049
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis.
    Aminian A; Al-Kurd A; Wilson R; Bena J; Fayazzadeh H; Singh T; Albaugh VL; Shariff FU; Rodriguez NA; Jin J; Brethauer SA; Dasarathy S; Alkhouri N; Schauer PR; McCullough AJ; Nissen SE
    JAMA; 2021 Nov; 326(20):2031-2042. PubMed ID: 34762106
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of laparoscopic sleeve gastrectomy on iron indices: 1 year follow-up.
    Hakeam HA; O'Regan PJ; Salem AM; Bamehriz FY; Eldali AM
    Obes Surg; 2009 Nov; 19(11):1491-6. PubMed ID: 19847572
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of NASH/NAFLD in people with obesity who are currently classified as metabolically healthy.
    Frey S; Patouraux S; Debs T; Gugenheim J; Anty R; Iannelli A
    Surg Obes Relat Dis; 2020 Dec; 16(12):2050-2057. PubMed ID: 32788075
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Utility of the ELF Test for Detecting Steatohepatitis in Morbid Obese Patients with Suspicion of Nonalcoholic Fatty Liver Disease.
    López IC; Aroca FG; Bernal MDF; Mompeán JAL; Bernal ÁB; Martínez AMH; Barba EM; Velasco JAN; Paricio PP
    Obes Surg; 2017 Sep; 27(9):2347-2353. PubMed ID: 28229316
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vaspin mRNA levels in the liver of morbidly obese women with nonalcoholic fatty liver disease.
    Waluga M; Kukla M; Żorniak M; Grabiec M; Kajor M; Dyaczyński M; Kowalski G; Żądło D; Berdowska A; Kotulski R; Bułdak RJ; Sawczyn T; Waluga E; Olczyk P; Hartleb M
    Pol J Pathol; 2017; 68(2):128-137. PubMed ID: 29025246
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development and Validation of a Novel Scoring System for Noninvasive Nonalcoholic Steatohepatitis Detection in Bariatric Patients.
    Billeter AT; Wloka S; Behnisch R; Albrecht T; Roessler S; Goeppert B; Mueller S; Nickel F; Müller B
    Obes Facts; 2021; 14(5):490-500. PubMed ID: 34419953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.